Mechanisms of drug resistance in acute myeloid leukemia
Top Cited Papers
Open Access
- 1 March 2019
- journal article
- review article
- Published by Informa UK Limited in OncoTargets and Therapy
- Vol. ume 12, 1937-1945
- https://doi.org/10.2147/ott.s191621
Abstract
Acute myeloid leukemia (AML) is a kind of malignant hematopoietic system disease characterized by abnormal proliferation, poor cell differentiation, and infiltration of bone marrow, peripheral blood, or other tissues. To date, the first-line treatment of AML is still based on daunorubicin and cytosine arabinoside or idarubicin and cytosine arabinoside regimen. However, the complete remission rate of AML is still not optimistic, especially in elderly patients, and the recurrence rate after complete remission is still high. The resistance of leukemia cells to chemotherapy drugs becomes the main obstacle in the treatment of AML. At present, the research on the mechanisms of drug resistance in AML is very active. This article will elaborate on the main mechanisms of drug resistance currently being studied, including drug resistance-related proteins and enzymes, gene alterations, micro RNAs, and signal pathways.Keywords
This publication has 94 references indexed in Scilit:
- Overexpression of heat shock transcription factor 1 enhances the resistance of melanoma cells to doxorubicin and paclitaxelBMC Cancer, 2013
- The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cellsCell Death & Disease, 2012
- Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemiaNature Medicine, 2012
- Mechanism of Generation of Therapy Related Leukemia in Response to Anti-Topoisomerase II AgentsInternational Journal of Environmental Research and Public Health, 2012
- Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemiaNature, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupBlood, 2010
- The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 ExpressionCancer Research, 2010
- Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemiaBlood, 2010